PainReform Ltd is a drug manufacturers-specialty & generic business based in the US. PainReform shares (PRFX) are listed on the NASDAQ and all prices are listed in US Dollars. PainReform employs 1 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in PainReform
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – PRFX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
PainReform stock price (NASDAQ: PRFX)Use our graph to track the performance of PRFX stocks over time.
PainReform shares at a glance
|Latest market close||$3.00|
|52-week range||$2.18 - $7.85|
|50-day moving average||$2.96|
|200-day moving average||$3.94|
|Wall St. target price||$10.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||N/A|
Buy PainReform shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy PainReform stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
PainReform price performance over time
|1 week (2021-07-18)||N/A|
|1 month (2021-06-29)||2.74%|
|3 months (2021-04-29)||-12.28%|
|6 months (2021-01-25)||N/A|
|1 year (2020-07-25)||N/A|
|2 years (2019-07-25)||N/A|
|3 years (2018-07-25)||N/A|
|5 years (2016-07-25)||N/A|
|Gross profit TTM||$0|
|Return on assets TTM||-20.15%|
|Return on equity TTM||-64.93%|
|Market capitalisation||$40.2 million|
TTM: trailing 12 months
Shorting PainReform shares
There are currently 69,503 PainReform shares held short by investors – that's known as PainReform's "short interest". This figure is 2.7% up from 67,676 last month.
There are a few different ways that this level of interest in shorting PainReform shares can be evaluated.
PainReform's "short interest ratio" (SIR)
PainReform's "short interest ratio" (SIR) is the quantity of PainReform shares currently shorted divided by the average quantity of PainReform shares traded daily (recently around 139006). PainReform's SIR currently stands at 0.5. In other words for every 100,000 PainReform shares traded daily on the market, roughly 500 shares are currently held short.
However PainReform's short interest can also be evaluated against the total number of PainReform shares, or, against the total number of tradable PainReform shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case PainReform's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 PainReform shares in existence, roughly 10 shares are currently held short) or 0.0193% of the tradable shares (for every 100,000 tradable PainReform shares, roughly 19 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against PainReform.
Find out more about how you can short PainReform stock.
PainReform share dividends
We're not expecting PainReform to pay a dividend over the next 12 months.
PainReform Ltd. , a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel. .
Stocks similar to PainReform
PainReform in the news
74 Biggest Movers From Yesterday
50 Stocks Moving In Friday's Mid-Day Session
32 Stocks Moving in Friday's Pre-Market Session
Frequently asked questionsWhat percentage of PainReform is owned by insiders or institutions?
Currently 23.098% of PainReform shares are held by insiders and 45.569% by institutions. How many people work for PainReform?
Latest data suggests 1 work at PainReform. When does the fiscal year end for PainReform?
PainReform's fiscal year ends in December. Where is PainReform based?
PainReform's address is: 4 Bruria Street, Tel Aviv, Israel, 6745442 What is PainReform's ISIN number?
PainReform's international securities identification number is: IL0011651580
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert